Should I Buy Viking Therapeutics (VKTX)? Finance YouTuber Analysis

The YouTuber is buying Viking Therapeutics, a biopharmaceutical company with promising GLP-1 drugs in trials for weight loss and thyroid metabolic disorders. Despite being a speculative stock with no current revenue, its $7 billion market cap allows for significant growth. The company is managing its debt and expenses well, and analysts project a 79% upside, making it an attractive long-term play.

“I give them a 10 because they have a long Runway given the breadth of drugs that they have in the pipeline and for potential I give them a solid nine”

The YouTuber recommends Viking Therapeutics for a short-term swing trade, noting its recent strong performance (up 88.75% today and 3% in after-hours). He mentions its focus on developing therapies for metabolic and endocrine disorders.

“Viking Therapeutics ticker symbol vktx sitting at $88.75 % on a day up another 3% in after hours genx Therapeutics was up 229 per today and up another 1 and a half% in after hours okay Viking therapeutic engages in the development of the therapies of metabolic and indoctrinator”